Cargando…

Basal C-peptide Level as a Surrogate Marker of Subclinical Atherosclerosis in Type 2 Diabetic Patients

BACKGROUND: Recent studies have revealed that C-peptide induces smooth muscle cell proliferation and causes human atherosclerotic lesions in diabetic patients. The present study was designed to examine whether the basal C-peptide levels correlate with cardiovascular risk in type 2 diabetes mellitus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Sung-Tae, Kim, Byung-Joon, Lim, Dong-Mee, Song, In-Geol, Jung, Jang-Han, Lee, Kang-Woo, Park, Keun-Young, Cho, Youn-Zoo, Lee, Dae-Ho, Koh, Gwan-Pyo
Formato:	Texto
Lenguaje:	English
Publicado:	Korean Diabetes Association 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080577/ https://www.ncbi.nlm.nih.gov/pubmed/21537412 http://dx.doi.org/10.4093/dmj.2011.35.1.41

Ejemplares similares

Response: Basal C-peptide Level as a Surrogate Marker of Subclinical Atherosclerosis in Type 2 Diabetic Patients (Diabetes Metab J 2011;35:41-9)
por: Kim, Sung-Tae, et al.
Publicado: (2011)

Correlations between Glucagon Stimulated C-peptide Levels and Microvascular Complications in Type 2 Diabetes Patients
por: Yoon, Hye-Jin, et al.
Publicado: (2012)

Letter: Basal C-peptide Level as a Surrogate Marker of Subclinical Atherosclerosis in Type 2 Diabetes Patients (Diabetes Metab J 2011;35:41-9)
por: Lee, Min Suk, et al.
Publicado: (2011)

Role of Surrogate Markers of Atherosclerosis in Clinical and Subclinical Thyroidism
por: Gunduz, Mehmet, et al.
Publicado: (2012)

Diabetes, Insulin Resistance and Atherosclerosis Surrogates in Patients With Coronary Atherosclerosis
por: Park, Hyun-Woong, et al.
Publicado: (2010)

FMD and CIMT: Surrogate Markers of Atherosclerosis in Subclinical and Overt Hypothyroidism in Sub Himalyan Region
por: Kumari, Bandana, et al.
Publicado: (2021)

Normal-weight obesity is associated with increased risk of subclinical atherosclerosis
por: Kim, Sohee, et al.
Publicado: (2015)

Clinical significance of subclinical atherosclerosis in retinal vein occlusion
por: Lyu, Minhyung, et al.
Publicado: (2021)

Subclinical thyroid dysfunction and risk of carotid atherosclerosis
por: Kim, Hosu, et al.
Publicado: (2017)

Diabetes and Subclinical Coronary Atherosclerosis
por: Lee, Chang Hoon, et al.
Publicado: (2018)

Subclinical atherosclerosis in patients with rheumatoid arthritis by utilizing carotid intima-media thickness as a surrogate marker
por: Mohan, Alladi, et al.
Publicado: (2014)

Cardiovascular Calcification as a Marker of Increased Cardiovascular Risk and a Surrogate for Subclinical Atherosclerosis: Role of Echocardiography
por: Faggiano, Andrea, et al.
Publicado: (2021)

Association of gamma-glutamyl transferase with subclinical coronary atherosclerosis and cardiac outcomes in non-alcoholics
por: Kim, Yong-Giun, et al.
Publicado: (2020)

Impact of Diabetes Control on Subclinical Atherosclerosis: Analysis from Coronary Computed Tomographic Angiography Registry
por: Park, Gyung-Min, et al.
Publicado: (2020)

The Role of Age in Subclinical Atherosclerosis in Asian People Living with Human Immunodeficiency Virus
por: Park, Sunghee, et al.
Publicado: (2022)

Homocysteine is not a risk factor for subclinical coronary atherosclerosis in asymptomatic individuals
por: Park, Sangwoo, et al.
Publicado: (2020)

Non-Alcoholic Fatty Liver Disease, a Marker of Subclinical Atherosclerosis Applicable Only to Metabolic Syndrome?: Time to Organize the Connection between Metabolism and Atherosclerosis
por: Lee, Seung-Pyo
Publicado: (2012)

Serum gamma-glutamyltransferase is not associated with subclinical atherosclerosis in patients with type 2 diabetes
por: Yoon, Hye Eun, et al.
Publicado: (2016)

Differential impact of metabolic syndrome on subclinical atherosclerosis according to the presence of diabetes
por: Won, Ki-Bum, et al.
Publicado: (2013)

The effect of levothyroxine treatment in individuals with subclinical hypothyroidism on surrogate markers of atherosclerosis: a meta-analysis of randomized controlled trials
por: Swaid, Bakr, et al.
Publicado: (2019)

Marital Status and Subclinical Coronary Atherosclerosis in Asymptomatic Individuals
por: Ann, Soe Hee, et al.
Publicado: (2022)

Variability of the Plasma Lipidome and Subclinical Coronary Atherosclerosis
por: Tan, Sock Hwee, et al.
Publicado: (2021)

Lower Zinc Bioavailability May Be Related to Higher Risk of Subclinical Atherosclerosis in Korean Adults
por: Jung, Su Kyoung, et al.
Publicado: (2013)

Subclinical atherosclerosis in patients with psoriasis
por: Balta, Ilknur, et al.
Publicado: (2015)

Predictors of subclinical atherosclerosis in HIV
por: Fernández Soto, Julia, et al.
Publicado: (2023)

Research Note: Embryonic viability by weight difference between donor and surrogate eggs in a surrogate eggshell incubation system
por: Yang, Hyeon, et al.
Publicado: (2022)

The pathophysiological role of dendritic cell subsets in psoriasis
por: Kim, Tae-Gyun, et al.
Publicado: (2014)

Subclinical Ulnar Neuropathy at the Elbow in Diabetic Patients
por: Jang, Ji Eun, et al.
Publicado: (2014)

Noninvasive indicators of atherosclerosis in subclinical hypothyroidism
por: Kilic, Ismail Dogu, et al.
Publicado: (2013)

Association of Fat Density With Subclinical Atherosclerosis
por: Alvey, Nicholas J., et al.
Publicado: (2014)

Subclinical atherosclerosis: how and when to treat it?
por: Gatto, Laura, et al.
Publicado: (2020)

Biomarkers of subclinical atherosclerosis in patients with psoriasis
por: Kaiser, Hannah, et al.
Publicado: (2021)

Association of Hepatic Steatosis With Subclinical Atherosclerosis: Systematic Review and Meta‐Analysis
por: Kapuria, Devika, et al.
Publicado: (2018)

Evaluation of Subclinical Extension of Basal Cell Carcinoma
por: Beiraghi Toosi, Arash, et al.
Publicado: (2017)

C-Type Natriuretic Peptide as a Surrogate Marker in Variant Angina Pectoris
por: Lee, Dong-Hyeon, et al.
Publicado: (2013)

B-type natriuretic peptide as a surrogate marker for survival in patients undergoing cardiac surgery
por: Lim, Ju Yong, et al.
Publicado: (2021)

Endovascular and Clinical Outcomes of Vertebrobasilar Intracranial Atherosclerosis-Related Large Vessel Occlusion
por: Baek, Jang-Hyun, et al.
Publicado: (2019)

Decreased Renal Function Is a Risk Factor for Subclinical Coronary Atherosclerosis in Korean Postmenopausal Women
por: Yun, Bo Hyon, et al.
Publicado: (2016)

Biomarkers of Subclinical Atherosclerosis in Patients with Autoimmune Disorders
por: Profumo, Elisabetta, et al.
Publicado: (2012)

The Association between Subclinical Atherosclerosis and Uterine Fibroids
por: He, Yuan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_51a1s94ek2h1klsn8vtf56l41v